TITLE

More placebo use promoted in Germany

AUTHOR(S)
Kupferschmidt, Kai
PUB. DATE
July 2011
SOURCE
CMAJ: Canadian Medical Association Journal;7/12/2011, Vol. 183 Issue 10, pE633
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the promotion of more usage of the placebo in Germany. It mentions that the German Medical Association has spent years to asses the scientific literature of placebos. It offers ethics recommend for placebo treatment in clinical practice, including the benefits which the patient could attain in a specific condition, and whether the recommendation of its usage could be made without deception and be consistent with informed consent.
ACCESSION #
64610618

 

Related Articles

  • Informed Consent and the Use of Placebo in Poland: Ethical and Legal Aspects. Zaborowski, Piotr; Górski, Adam // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p167 

    The concept of informed consent was one of the most fruitful ideas that deeply changed the relationships between physicians and their patients from paternalism to respect for the personal autonomy of subjects needing professional medical care. The great progress in medicine, also involving the...

  • The CIOMS View on the Use of Placebo in Clinical Trials. Idänpään-Heikkilä, Juhana E.; Fluss, Sev // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p23 

    Based on worldwide consultations with experts in science and ethics the revised CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects provide guidance on when the use of placebo as a comparator in clinical research is ethically acceptable. The article...

  • Pediatric clinical trials: current scenario in the Asia Pacific region. Saldanha, Lisa Marie; Saumya Nayak; Sng, Adeline; Mei-Ling Long; Schrader, Elisabeth; Rahman, Amanur; Lansang, Elvira Zenaida; Wai, Karen; Ken Lee // Pediatric Health, Medicine & Therapeutics;2013, Vol. 4, p47 

    Objective: This site survey was conducted to understand the current pediatric clinical trial landscape across countries in the Asia Pacific region, specifically in terms of interest, experience, capabilities, requirements of the ethics committee, patient availability, and overall challenges...

  • Le placebo, quel rôle dans la recherche clinique ? Aspects pharmacologiques et dimension éthique. PETRON-BARDOU, Camille; VENEL, Véronique; BARDOT, Virginie; AIRAGNES, Guillaume; LECOVEC, Gaëlle; HAMIDA, Myriam CAROF-BEN; DIQUET, Bertrand; LASCAR, Philippe // Perspectives Psychiatriques;oct-dec2013, Vol. 52 Issue 4, p326 

    The response following the administration of a substance by definition pharmacologically inactive constitutes the placebo effect. Intrication of various mechanisms makes it impossible to analyze them separately and complicates the study of the placebo effect. This is a global therapeutic...

  • Placebo treatments, informed consent and ‘the grip of a false picture’. Glackin, Shane Nicholas // Journal of Medical Ethics;Aug2015, Vol. 41 Issue 8, p669 

    It is widely supposed that the prescription of placebo treatments to patients for therapeutic purposes is ethically problematic on the grounds that the patient cannot give informed consent to the treatment, and is therefore deceived by the physician. This claim, I argue, rests on two confusions:...

  • Sham Surgury: An Ethical Analysis. Miller, Franklin G. // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p157 

    Surgical clinical trials have seldom used a "sham" or placebo surgical procedure as a control, owing to ethical concerns. Recently, several ethical commentators have argued that sham surgery is either inherently or presumptively unethical. In this article I contend that these arguments are...

  • The ethics of placebo treatments in clinical practice: a reply to Glackin. Barnhill, Anne; Miller, Franklin G // Journal of Medical Ethics;Aug2015, Vol. 41 Issue 8, p673 

    In ‘Placebo treatments, informed consent, and “the grip of a false picture”’ Shane Nicholas Glackin argues that if a physician offers a patient an inert placebo with the following disclosure, this is compatible with informed consent and is not deceptive: ‘I would...

  • The Definition of Placebo in the Informed Consent Forms of Clinical Trials. Hernández, Astrid; Baños, Josep-E.; Llop, Cristina; Farré, Magí // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Aim: Lack of knowledge concerning the nature of placebo and why it is necessary may influence the participation of patients in clinical trials. The objective of the present study is to review how placebo is described in written information for participants in clinical trials to be evaluated by...

  • Probing Ethics in Human Research. Sodeke, Stephen O. // Applied Clinical Trials;Feb2005, Vol. 14 Issue 2, p40 

    This article focuses on the aspect of ethics in clinical trials. Ample evidence suggests that the ethical problems of involving humans in scientific experimentation have a long history. Today, ethical lapses in clinical research have involved informed consent, parental consent, and assent. Also...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics